SCHEMBL20745977

SCHEMBL20745977

Clc1nc(I)cc2sccc12

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 8/20 0.35
CSNK2B P67870 8/20 0.35
CSNK2A1 P68400 8/20 0.35
HTR2C P28335 1/20 0.33
KDM4E B2RXH2 2/20 0.32
CYP2A6 P11509 1/20 0.32
MAPT P10636 2/20 0.30
TSHR P16473 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
PPARG P37231 1/20 0.30
HTT P42858 1/20 0.30
NCOA2 Q15596 1/20 0.30
NCOA1 Q15788 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
NCOA3 Q9Y6Q9 1/20 0.30
DYRK1A Q13627 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25346159 0.80 CSNK2A2 (0.37) CSNK2A2CSNK2BCSNK2A1HTR2CKDM4E
SCHEMBL31155205 0.80 CSNK2A2 (0.37) CSNK2A2CSNK2BCSNK2A1HTR2CKDM4E
SCHEMBL8172184 0.77 KDM4E (0.39) CSNK2A2CSNK2BCSNK2A1HTR2CKDM4E
SCHEMBL6240033 0.77 CSNK2A2 (0.35) CSNK2A2CSNK2BCSNK2A1HTR2CKDM4E
SCHEMBL5198824 0.73 SMN1; SMN2 (0.36) CSNK2A2CSNK2BCSNK2A1HTR2CKDM4E
SCHEMBL3357775 0.70 NOS3 (0.37) CSNK2A2CSNK2BCSNK2A1HTR2CKDM4E
SCHEMBL4773700 0.69 MAPT (0.39) KDM4EMAPTALDH1A1
SCHEMBL4769008 0.66 KDM4E (0.46) KDM4EMAPTALDH1A1HPGDHTT
SCHEMBL29792714 0.65 HTR2C (0.45) HTR2CKDM4EMAPTALDH1A1HPGD
SCHEMBL760085 0.65 HTR2C (0.45) HTR2CKDM4EMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652184-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-05-20 EP disclosed
WO-2019035911-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed